Triad Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$344K Buy
3,342
+545
+19% +$58.7K 0.12% 65
2023
Q2
$323K Sell
2,797
-21
-0.7% -$2.38K 0.13% 66
2023
Q1
$300K Sell
2,818
-96
-3% -$10.4K 0.13% 74
2022
Q4
$323K Buy
2,914
+19
+0.7% +$1.94K 0.14% 76
2022
Q3
$249K Buy
2,895
+40
+1% +$3.57K 0.14% 83
2022
Q2
$260K Sell
2,855
-39
-1% -$3.46K 0.14% 83
2022
Q1
$237K Sell
2,894
-294
-9% -$23.2K 0.13% 98
2021
Q4
$244K Buy
+3,188
New +$254K 0.14% 106

Other funds holding MRK

Triad Financial Advisors's MRK Position: Q3 2023 in Review

Triad Financial Advisors increased its Merck (MRK) stake by 19% in Q3 2023, buying an estimated $58.7K and bringing the position to 3,342 shares worth $344K. The position accounts for 0.12% of the portfolio, ranked #65.

Triad Financial Advisors first reported a position in MRK in Q4 2021 and has held it in 8 quarters since. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Triad Financial Advisors held 3,342 shares of Merck worth $344K as of Q3 2023.
  • Triad Financial Advisors bought 545 Merck shares in Q3 2023, an estimated $58.7K.
  • Merck made up 0.12% of Triad Financial Advisors's portfolio in Q3 2023, its #65 holding.
  • Triad Financial Advisors first reported a position in Merck in Q4 2021 and has held it in 8 quarters since.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Triad Financial Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.